Warburg Pincus, the pioneer of global growth investing, announces that a Warburg Pincus-led investor group has agreed to acquire a controlling interest in PANTHERx Rare, the leading independent rare pharmacy in the United States, from Nautic Partners, General Atlantic, and The Vistria Group. Nautic Partners and PANTHERx management will remain significant shareholders. The investment will support PANTHERx as a category-defining rare disease care platform while preserving its patient-first and manufacturer-aligned model. PANTHERx pioneered the rare pharmacy model and serves as a trusted partner across the rare disease community.
Read the full article: Warburg Pincus-Led Investor Group Agrees to Acquire Controlling Interest in PANTHERx® Rare //
Source: https://www.prnewswire.com/news-releases/warburg-pincus-led-investor-group-agrees-to-acquire-controlling-interest-in-pantherx-rare-302824163.html